Strumento inattivo

Altre lingue Evogene Ltd Other OTC

Azioni

IL0011050551

Prezzo di chiusura Other OTC Altri mercati azionari
- ^USD	-

23/05	Evogene Ltd. Fornisce una previsione di fatturato per l'anno 2024	CI
23/05	Transcript : Evogene Ltd., Q1 2024 Earnings Call, May 23, 2024

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country - Evogene	26/06
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country	25/06
Evogene : Other Report or Announcement	20/06
Evogene : Other Report or Announcement	17/06
Evogene : Lavie Bio Company Presentation	09/06
Evogene : Immediate Report of Meeting	06/06
Evogene : Corporate Presentation	29/05
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma - Evogene	24/05
Evogene : Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma	23/05
Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M	23/05
Evogene Reports First Quarter 2024 Financial Results - Evogene	23/05
Evogene Ltd. Provides Revenue Guidance for the Year 2024	23/05
Evogene : Q1 2024 Consolidated Financial Statements	23/05
Evogene: Q1 Earnings Snapshot	23/05
Evogene Reports First Quarter 2024 Financial Results	23/05
Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds - Evogene	22/05
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds	21/05
Evogene Schedules First Quarter 2024 Financial Results Release - Evogene	09/05
Schedules First Quarter 2024 Financial Results Release on May 23, 2024,conference call to discuss the results at 9:00 AM EST	09/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Evogene Ltd Other OTC

Azioni

IL0011050551

Altre lingue

Filtri